C12N2770/24334 - CPC Classification Index

#1

20250288663

2025-09-18

IMMUNOSTIMULATORY PREPARATION AND COSMETIC, FOOD, FEED ADDITIVE, AND QUASI-PHARMACEUTICAL PRODUCT CONTAINING THE IMMUNOSTIMULATORY PREPARATION

#2

20250230194

2025-07-17

RECOMBINANT CLASSICAL SWINE FEVER VIRUS E2 PROTEIN WITH B/C DOMAIN SWAPPING

#3

20240358825

2024-10-31

Novel Adjuvant Compositions

#4

20240209033

2024-06-27

MAMMALIAN CELL LINE AND METHOD FOR PRODUCING SOLUBLE E2 RECOMBINANT ANTIGEN OF CLASSICAL SWINE FEVER VIRUS USING THE SAME AND APPLICATION THEREOF

#5

20240102031

2024-03-28

OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS

#6

20230181710

2023-06-15

RECOMBINANT CLASSICAL SWINE FEVER VIRUS

#7

20220347295

2022-11-03

Vaccine delivery method

#8

20220062407

2022-03-03

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

#9

20210338810

2021-11-04

Adjuvant compositions

#10

20210308248

2021-10-07

Isolation of a novel pestivirus causing congenital tremor A

#11

20210230612

2021-07-29

Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast

#12

20210101962

2021-04-08

Mosaic chimeric viral vaccine particle

#13

20210015916

2021-01-21

Vaccine delivery method

#14

20200079838

2020-03-12

Mosaic chimeric viral vaccine particle

#15

20190269772

2019-09-05

Heat-resistant protective agent, room-temperature-preserved live classical swine fever vaccine, and preparation method and application thereof

#16

20190240311

2019-08-08

PESTIVIRUS MARKER VACCINE

#17

20190008953

2019-01-10

Adjuvant compositions

#18

20180353596

2018-12-13

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

#19

20180171307

2018-06-21

Pestivirus vaccines for congenital tremors

#20

20180094046

2018-04-05

Mosaic chimeric viral vaccine particle

#21

20180021424

2018-01-25

Liposomal adjuvant compositions

#22

20170342387

2017-11-30

Pestivirus

#23

20170304434

2017-10-26

Adjuvant compositions

#24

20170202958

2017-07-20

VACCINE DELIVERY METHOD

#25

20170128563

2017-05-11

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

#26

20170119870

2017-05-04

Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein

#27

20170058266

2017-03-02

vaccines for congenital tremors

#28

20170029470

2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#29

20160339096

2016-11-24

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

#30

20160331826

2016-11-17

Baculovirus display vectors and uses thereof

#31

20160313330

2016-10-27

Diagnostic test for CSFV antibodies

#32

20160229896

2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#33

20160222472

2016-08-04

Pestivirus species

#34

20160068575

2016-03-10

Recombinant baculovirus vector and uses thereof

#35

20160030556

2016-02-04

Bovine virus vaccines that are liquid stable

#36

20160008449

2016-01-14

CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE

#37

20150250866

2015-09-10

Live attenuated antigenically marked classical swine fever vaccine

#38

20140363466

2014-12-11

METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS

#39

20140294889

2014-10-02

Use of the PACAP as a molecular adjuvant for vaccines

#40

20140271710

2014-09-18

Liquid stable bovine virus vaccines

#41

20140271709

2014-09-18

Bovine virus vaccines that are liquid stable

#42

20140154285

2014-06-05

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#43

20140147466

2014-05-29

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

#44

20140127259

2014-05-08

Compositions and methods for vaccinating cattle

#45

20140099338

2014-04-10

Yeast expressed classical swine fever virus glycoprotein E2 and use thereof

#46

20140093535

2014-04-03

Combined vaccines for prevention of porcine virus infections

#47

20140056940

2014-02-27

Adjuvant compositions

#48

20130195892

2013-08-01

BVDV vaccine

#49

20130129762

2013-05-23

Marker vaccine for classical swine fever

#50

20130084306

2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

#51

20130004547

2013-01-03

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

#52

20120258127

2012-10-11

VACCINE PEPTIDES

#53

20120237519

2012-09-20

Pestivirus species

#54

20120171230

2012-07-05

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

#55

20120148620

2012-06-14

COMPOSITIONS AND METHODS FOR VACCINATING CATTLE

#56

20120021001

2012-01-26

MARKED BOVINE VIRAL DIARRHEA VIRUS VACCINES

#57

20120014992

2012-01-19

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

#58

20110314562

2011-12-22

Insect Infection Method for Production of Proteins

#59

20110293659

2011-12-01

Method for the oral/mucosal vaccination by means of recombinant yeasts

#60

20110117126

2011-05-19

Attenuated pestivirus

#61

20110061136

2011-03-10

Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof

#62

20110052564

2011-03-03

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

#63

20110038886

2011-02-17

-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

#64

20110008376

2011-01-13

IMMUNOGENIC COMPOSITIONS CAPABLE OF ACTIVATING T-CELLS

#65

20100297175

2010-11-25

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

#66

20100221275

2010-09-02

PROTECTION OF AN ANIMAL AGAINST PESTIVIRUS INFECTION

#67

20100203063

2010-08-12

Pestivirus species

#68

20100178301

2010-07-15

Method of treating pregnant cows and/or heifers

#69

20100104597

2010-04-29

N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

#70

20100028384

2010-02-04

YEAST EXPRESSED CLASSICAL SWINE FEVER VIRUS GLYCOPROTEIN E2 AND USE THEREOF

#71

20090324641

2009-12-31

Adjuvant compositions

#72

20090304633

2009-12-10

Chimeric vaccine antigens against classical swine fever virus

#73

20090232846

2009-09-17

Pestivirus mutant for use in a vaccine

#74

20090226485

2009-09-10

Recombinant porcine adenovirus vector

#75

20090191228

2009-07-30

Immunogenic compositions capable of activating T-cells

#76

20090181051

2009-07-16

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

#77

20090142377

2009-06-04

Immunogenic compositions

#78

20090136536

2009-05-28

Recombinant Subunit Vaccine

#79

20090110697

2009-04-30

Inactivated bovine herpes virus-1 and methods

#80

20090068223

2009-03-12

COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS

#81

20090028902

2009-01-29

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

#82

20080305130

2008-12-11

Marked Bovine Viral Diarrhea Virus Vaccines

#83

20080286302

2008-11-20

Safe mutant viral vaccines

#84

20080267997

2008-10-30

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

#85

20080260778

2008-10-23

Method of Vaccination Against Testicular Bvdv Infection

#86

20080220017

2008-09-11

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

#87

20080220016

2008-09-11

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

#88

20070280955

2007-12-06

Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

#89

20070212376

2007-09-13

Method of treating and preventing infectious diseases

#90

20070172877

2007-07-26

Methods for preventing cattle reproductive diseases

#91

20070154943

2007-07-05

Methods for preventing cattle reproductive diseases

#92

20070031923

2007-02-08

Method of making modified immunodeficiency virus particles

#93

20060263387

2006-11-23

Recombinant porcine adenovirus vector

#94

20060252049

2006-11-09

Growth-promoting and immunizing subcutaneous implant

#95

20050220814

2005-10-06

Microfluidized oil-in-water emulsions and vaccine compositions

#96

20050220813

2005-10-06

Non-spreading pestivirus

#97

20050130127

2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

#98

20050053621

2005-03-10

Safe mutant viral vaccines

#99

20050032222

2005-02-10

Modified viral particles with immunogenic properties and reduced lipid content